These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22521566)

  • 21. Evidence for indications of fresh frozen plasma.
    Stanworth SJ; Hyde CJ; Murphy MF
    Transfus Clin Biol; 2007 Dec; 14(6):551-6. PubMed ID: 18430602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical use of fresh-frozen plasma and cryoprecipitate in neonatal intensive care unit.
    Motta M; Del Vecchio A; Radicioni M
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 1():129-31. PubMed ID: 21942611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood product support of coagulation.
    Moormeier J
    Mo Med; 2009; 106(1):65-8. PubMed ID: 19245127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should plasma be transfused prophylactically before invasive procedures?
    Holland L; Sarode R
    Curr Opin Hematol; 2006 Nov; 13(6):447-51. PubMed ID: 17053457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelets, frozen plasma, and cryoprecipitate: what is the clinical evidence for their use in the neonatal intensive care unit?
    Poterjoy BS; Josephson CD
    Semin Perinatol; 2009 Feb; 33(1):66-74. PubMed ID: 19167583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study.
    Youssef WI; Salazar F; Dasarathy S; Beddow T; Mullen KD
    Am J Gastroenterol; 2003 Jun; 98(6):1391-4. PubMed ID: 12818286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
    Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward rational fresh frozen plasma transfusion: The effect of plasma transfusion on coagulation test results.
    Holland LL; Brooks JP
    Am J Clin Pathol; 2006 Jul; 126(1):133-9. PubMed ID: 16753596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on transfusion medicine.
    Shander A; Goodnough LT
    Pharmacotherapy; 2007 Sep; 27(9 Pt 2):57S-68S. PubMed ID: 17723109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of fresh-frozen plasma at Royal Darwin Hospital: a retrospective audit.
    Moylan S; Szabo F; Scott H; Kwok G
    Intern Med J; 2008 Sep; 38(9):686-91. PubMed ID: 19143886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Plasma for Acquired Coagulation Factor Deficiencies in Critical Care.
    Shah A; McKechnie S; Stanworth S
    Semin Thromb Hemost; 2016 Mar; 42(2):95-101. PubMed ID: 26716502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of fresh frozen plasma usage at the University Hospital Center Rijeka.
    Balen S; Caser L; Ivanković E; Samardzija M; Ivanković Z; Vcev A
    Coll Antropol; 2009 Dec; 33(4):1375-81. PubMed ID: 20102096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement in fresh frozen plasma transfusion practice: results of an outcome audit.
    Kakkar N; Kaur R; Dhanoa J
    Transfus Med; 2004 Jun; 14(3):231-5. PubMed ID: 15180815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of plasma in the management of central nervous system bleeding: evidence-based consensus recommendations.
    Shander A; Michelson EA; Sarani B; Flaherty ML; Shulman IA
    Adv Ther; 2014 Jan; 31(1):66-90. PubMed ID: 24338742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coagulation defects do not predict blood product requirements during liver transplantation.
    Massicotte L; Beaulieu D; Thibeault L; Roy JD; Marleau D; Lapointe R; Roy A
    Transplantation; 2008 Apr; 85(7):956-62. PubMed ID: 18408574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Algorithmic and consultative integration of transfusion medicine and coagulation: a personalized medicine approach with reduced blood component utilization.
    Brown RE; Dorion RP; Trowbridge C; Stammers AH; Fitt W; Davis J
    Ann Clin Lab Sci; 2011; 41(3):211-6. PubMed ID: 22075502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy.
    Stanworth SJ
    Hematology Am Soc Hematol Educ Program; 2007; ():179-86. PubMed ID: 18024627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations.
    Massicotte L; Lenis S; Thibeault L; Sassine MP; Seal RF; Roy A
    Liver Transpl; 2006 Jan; 12(1):117-23. PubMed ID: 16382461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood component support in acquired coagulopathic conditions: is there a method to the madness?
    Pandit TN; Sarode R
    Am J Hematol; 2012 May; 87 Suppl 1():S56-62. PubMed ID: 22473878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.